Added value of serum hormone measurements in risk prediction models for breast cancer for women not using exogenous hormones: Results from the EPIC cohort. (Clinical Cancer Research, 2017)

(untitled) - Husing, A; Fortner, R; Kuhn, T; Overvad, K; Tjonneland, A; Olsen, A; Boutron-Ruault, M; Severi, G; Fournier, A; Boeing, H; Trichopoulou, A; Benetou, V; et al.